{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:26:22Z","timestamp":1722889582432},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00535-011-0479-6","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T15:19:57Z","timestamp":1320247197000},"page":"249-255","source":"Crossref","is-referenced-by-count":5,"title":["Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis"],"prefix":"10.1007","volume":"47","author":[{"name":"The J-FAST Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Miwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyasu","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"479_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","volume":"5","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17\u201326.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"479_CR2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1440-1746.2003.02932.x","volume":"18","author":"M Inamori","year":"2003","unstructured":"Inamori M, Togawa J, Nagase H, Abe Y, Umezawa T, Nakajima A, et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol. 2003;18:172\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl","key":"479_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bpg.2004.06.015","volume":"18","author":"A Pilotto","year":"2004","unstructured":"Pilotto A. Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2004;18(Suppl):73\u201381.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"479_CR4","first-page":"1053","volume":"90","author":"MJ Collen","year":"1995","unstructured":"Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol. 1995;90:1053\u20137.","journal-title":"Am J Gastroenterol"},{"key":"479_CR5","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","volume":"112","author":"N Chiba","year":"1997","unstructured":"Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112:1798\u2013810.","journal-title":"Gastroenterology"},{"key":"479_CR6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1365-2036.2003.01593.x","volume":"17","author":"A Pilotto","year":"2003","unstructured":"Pilotto A, Leandro G, Franceschi M. Ageing and Acid-Related Disease Study Group. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Aliment Pharmacol Ther. 2003;17:1399\u2013406.","journal-title":"Aliment Pharmacol Ther"},{"key":"479_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000106453","volume":"75","author":"TK Cheung","year":"2007","unstructured":"Cheung TK, Wong WM, Wong NY, Chan CK, Fung J, Yuen MF, et al. Symptom resolution does not predict healing of erosive oesophagitis in Chinese. Digestion. 2007;75:128\u201334.","journal-title":"Digestion"},{"key":"479_CR8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.2003.01539.x","volume":"17","author":"M Kawamura","year":"2003","unstructured":"Kawamura M, Ohara S, Koike T, Iijima K, Suzuki J, Kayaba S, et al. The effects of lansoprazole on erosive reflux esophagitis are influenced by CYP2C19 polymorphism. Aliment Pharmacol Ther. 2003;17:965\u201373.","journal-title":"Aliment Pharmacol Ther"},{"key":"479_CR9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1365-2036.2002.01248.x","volume":"16","author":"M Frazzoni","year":"2002","unstructured":"Frazzoni M, De Micheli E, Grisendi A, Savarino V. Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. Aliment Pharmacol Ther. 2002;16:881\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"479_CR10","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1572-0241.2008.01979.x","volume":"103","author":"BS Sheu","year":"2008","unstructured":"Sheu BS, Chang WL, Cheng HC, Kao AW, Lu CC. Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole. Am J Gastroenterol. 2008;103:2209\u201314.","journal-title":"Am J Gastroenterol"},{"key":"479_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00535-010-0342-1","volume":"46","author":"M Hongo","year":"2010","unstructured":"Hongo M, Miwa H, Kusano M, J-FAST group. Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in Japan. J Gastroenterol. 2010;46:297\u2013304.","journal-title":"J Gastroenterol"},{"key":"479_CR12","volume-title":"How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey","author":"JE Ware","year":"2001","unstructured":"Ware JE, Kosinski M, Dewey JE, Gandek B. How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey. Lincoln: QualityMetric; 2001."},{"key":"479_CR13","unstructured":"Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version. Kyoto: Institute for Health Outcomes and Process Evaluation Research; 2004 (in Japanese)."},{"key":"479_CR14","first-page":"1459","volume":"62","author":"Y Hoshihara","year":"2004","unstructured":"Hoshihara Y. Endoscopic findings of GERD. Nippon Rinsho. 2004;62:1459\u201364. (in Japanese with English abstract).","journal-title":"Nippon Rinsho"},{"key":"479_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-006-1775-4","volume":"41","author":"M Hongo","year":"2006","unstructured":"Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol. 2006;41:95\u20139.","journal-title":"J Gastroenterol"},{"key":"479_CR16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888\u201391.","journal-title":"J Gastroenterol"},{"key":"479_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MCG.0b013e31802e849f","volume":"41","author":"R Fass","year":"2007","unstructured":"Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. J Clin Gastroenterol. 2007;41:437\u201344.","journal-title":"J Clin Gastroenterol"},{"key":"479_CR18","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s10620-006-9674-3","volume":"52","author":"M Kusano","year":"2007","unstructured":"Kusano M, Shimoyama Y, Kawamura O, Maeda M, Kuribayashi S, Nagoshi A, et al. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci. 2007;52:1673\u20137.","journal-title":"Dig Dis Sci"},{"key":"479_CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1440-1746.2008.05747.x","volume":"24","author":"A Danjo","year":"2009","unstructured":"Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, et al. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24:633\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"479_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0166-4328(99)00193-X","volume":"110","author":"JB Overmier","year":"2000","unstructured":"Overmier JB, Murison R. Anxiety and helplessness in the face of stress predisposes, precipitates, and sustains gastric ulceration. Behav Brain Res. 2000;110:161\u201374.","journal-title":"Behav Brain Res"},{"key":"479_CR21","first-page":"309","volume":"111","author":"D Mou","year":"1998","unstructured":"Mou D, Zhu X, Xu W, Du R. The pathogenetic role of endogenous angiotensin II in stress ulcer in obstructive jaundice rats. Chin Med J (Engl). 1998;111:309\u201312.","journal-title":"Chin Med J (Engl)"},{"key":"479_CR22","doi-asserted-by":"crossref","first-page":"G414","DOI":"10.1152\/ajpgi.00058.2003","volume":"285","author":"C Bregonzio","year":"2003","unstructured":"Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol. 2003;285:G414\u201323.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"479_CR23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00535-008-2290-6","volume":"44","author":"A Shiotani","year":"2009","unstructured":"Shiotani A, Sakakibara T, Yamanaka Y, Imamura H, Tarumi K, Manabe N, et al. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol. 2009;44:126\u201331.","journal-title":"J Gastroenterol"},{"key":"479_CR24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10620-010-1382-3","volume":"56","author":"A Shiotani","year":"2011","unstructured":"Shiotani A, Nishi R, Yamanaka Y, Murao T, Matsumoto H, Tarumi K, et al. Renin\u2013angiotensin system associated with risk of upper GI mucosal injury induced by low dose aspirin: renin angiotensin system genes\u2019 polymorphism. Dig Dis Sci. 2011;56:465\u201371.","journal-title":"Dig Dis Sci"},{"issue":"Suppl 3","key":"479_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.1999.00022.x","volume":"13","author":"T Ishizaki","year":"1999","unstructured":"Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors\u2014emphasis on rabeprazole. Aliment Pharmacol Ther. 1999;13(Suppl 3):27\u201336.","journal-title":"Aliment Pharmacol Ther"},{"key":"479_CR26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1291\/hypres.31.1549","volume":"31","author":"T Yin","year":"2008","unstructured":"Yin T, Maekawa K, Kamide K, et al. Genetic variations of CYP2C9 in 724 Japanese individuals and their impact on the antihypertensive effects of losartan. Hypertens Res. 2008;31:1549\u201357.","journal-title":"Hypertens Res"},{"key":"479_CR27","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","volume":"137","author":"RF Souza","year":"2009","unstructured":"Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang HY, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776\u201384.","journal-title":"Gastroenterology"},{"key":"479_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0953-6205(02)00090-0","volume":"13","author":"S Gudlaugsdottir","year":"2002","unstructured":"Gudlaugsdottir S, Verschuren W, Dees J, Stijnen T, Wilson J. Hypertension is frequently present in patients with reflux esophagitis or Barrett\u2019s esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med. 2002;13:369.","journal-title":"Eur J Intern Med"},{"issue":"Suppl 2","key":"479_CR29","first-page":"A-152","volume":"128","author":"F Moki","year":"2005","unstructured":"Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H. Reflux esophagitis as a lifestyle-related disease. Gastroenterology. 2005;128(Suppl 2):A-152.","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0479-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0479-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:37:56Z","timestamp":1559097476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0479-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0479-6","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}